198 related articles for article (PubMed ID: 34614294)
21. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases.
Goodman ZD; McNally PR; Davis DR; Ishak KG
Dig Dis Sci; 1995 Jun; 40(6):1232-42. PubMed ID: 7781439
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis.
Juliusson G; Imam M; Björnsson ES; Talwalkar JA; Lindor KD
Scand J Gastroenterol; 2016; 51(6):745-52. PubMed ID: 26776319
[TBL] [Abstract][Full Text] [Related]
23. Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid.
Sakauchi F; Mori M; Zeniya M; Toda G
J Epidemiol; 2006 Jan; 16(1):30-4. PubMed ID: 16369106
[TBL] [Abstract][Full Text] [Related]
24. Primary biliary cirrhosis in antimitochondrial antibody-negative patients: Chang Gung Memorial Hospital experience.
Tsou YK; Yeh CT
Chang Gung Med J; 2003 May; 26(5):323-9. PubMed ID: 12934848
[TBL] [Abstract][Full Text] [Related]
25. Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report.
Zhao DT; Liu YM; Han Y; Zhang HP; Zhao Y; Yan HP
Medicine (Baltimore); 2020 Jan; 99(3):e18856. PubMed ID: 32011506
[TBL] [Abstract][Full Text] [Related]
26. Clinical performance of AMA-M2, anti-gp210 and anti-sp100 antibody levels in primary biliary cholangitis: When detected by multiplex bead-based flow fluorescent immunoassay.
Wang Z; Li Y; Ren L; Li Y; Xu T; Li W; Gao W; Sun G; Liu M
Immun Inflamm Dis; 2024 Jan; 12(1):e1161. PubMed ID: 38270327
[TBL] [Abstract][Full Text] [Related]
27. Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
Natarajan Y; Tansel A; Patel P; Emologu K; Shukla R; Qureshi Z; El-Serag HB; Thrift AP; Kanwal F
Dig Dis Sci; 2021 Jul; 66(7):2439-2451. PubMed ID: 32743773
[TBL] [Abstract][Full Text] [Related]
28. [An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis].
Sun LM; Yan HP; Lou JL; Wang Y; Zhao Y; Yu YH; Zhang HP; Liu YM
Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):298-303. PubMed ID: 31082342
[No Abstract] [Full Text] [Related]
29. Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group.
Gatselis NK; Zachou K; Loza AJM; Cançado ELR; Arinaga-Hino T; Muratori P; Efe C; Floreani A; Invernizzi P; Takahashi A; Takaki A; Beretta-Piccoli BT; van Hoek B; Lytvyak E; Guedes LV; Purnak T; Cazzagon N; Lygoura V; Arvaniti P; Rigopoulou EI; Muratori L; Dalekos GN;
Eur J Intern Med; 2023 Oct; 116():43-50. PubMed ID: 37302951
[TBL] [Abstract][Full Text] [Related]
30. Characterization of overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis according to antimitochondrial antibodies status.
Alric L; Thebault S; Selves J; Peron JM; Mejdoubi S; Fortenfant F; Vinel JP
Gastroenterol Clin Biol; 2007 Jan; 31(1):11-6. PubMed ID: 17273127
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.
Gabeta S; Norman GL; Liaskos C; Papamichalis PA; Zografos T; Garagounis A; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2007 Jul; 27(4):378-87. PubMed ID: 17514501
[TBL] [Abstract][Full Text] [Related]
32. Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis?
Nakajima M; Shimizu H; Miyazaki A; Watanabe S; Kitami N; Sato N
J Gastroenterol; 1999 Oct; 34(5):607-12. PubMed ID: 10535489
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis.
Invernizzi P; Crosignani A; Battezzati PM; Covini G; De Valle G; Larghi A; Zuin M; Podda M
Hepatology; 1997 May; 25(5):1090-5. PubMed ID: 9141422
[TBL] [Abstract][Full Text] [Related]
34. Antimitochondrial antibody-negative primary biliary cirrhosis.
Mendes F; Lindor KD
Gastroenterol Clin North Am; 2008 Jun; 37(2):479-84, viii. PubMed ID: 18499032
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular Carcinoma in Primary Biliary Cholangitis.
Sy AM; Ferreira RD; John BV
Clin Liver Dis; 2022 Nov; 26(4):691-704. PubMed ID: 36270724
[TBL] [Abstract][Full Text] [Related]
36. Distinction between Mitochondrial Antibody-Positive and -Negative Primary Biliary Cholangitis.
Matli VVK; Dies DF; Pandit S; Wellman G; Morris JD
Case Rep Gastroenterol; 2023; 17(1):14-20. PubMed ID: 36742099
[TBL] [Abstract][Full Text] [Related]
37. [Differential characteristics of AMA-M2 autoantibody in primary biliary cirrhosis and non-PBC patients].
Sun L; Wang Y; Liu Y; Zhao Y; Zhang X; Wang Y; Zhao D; Zhang H; Ma Y
Zhonghua Gan Zang Bing Za Zhi; 2015 May; 23(5):343-9. PubMed ID: 26192239
[TBL] [Abstract][Full Text] [Related]
38. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis.
Zhang FK; Jia JD; Wang BE
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):288-91. PubMed ID: 15138128
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the primary biliary cholangitis-related serologic profile in a large cohort of Belgian systemic sclerosis patients.
Florin L; Rubben K; Vanhaecke A; Devreese K; De Keyser F; Smith V; Bonroy C
Clin Chem Lab Med; 2020 Feb; 58(3):416-423. PubMed ID: 31714880
[TBL] [Abstract][Full Text] [Related]
40. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
